A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
Abstract Background: Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with…
Abstract Background: Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with…
Abstract Human immunodeficiency virus type 1 (HIV-1) is known to provoke microglial immune responses which likely play a paramount role…
Abstract Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacological tolerance and receptor desensitization in…